Market Overview
đź“šDownload Full PDF Sample Copy of Market Report @
https://wwcw.businessmarketinsights.com/sample/TIPRE00025899
Cardiovascular needles are essential tools used in various cardiac surgeries, including open-heart procedures, valve repairs, heart transplants, coronary artery bypass grafts (CABG), and other related interventions. These needles are categorized into two types: single-use (eyeless) and multiple-use (eyed) variants. Typically manufactured from high-grade stainless-steel alloys—such as Surgalloy and Ethalloy—with high nickel content, they ensure durability and precision in surgical applications.
The rising global incidence of cardiovascular diseases is expected to fuel demand for cardiovascular needles in the coming years, driving market growth. However, the COVID-19 pandemic has significantly disrupted cardiac surgery volumes across Europe and the United States, leading to postponed operations, delayed treatments, and the reallocation of critical care resources.
In the UK, the British Heart Foundation reported a 22% decline in heart-related procedures in 2020, with approximately 371,000 surgeries performed compared to 473,000 in 2019. Major operations, including coronary bypasses and valve surgeries, dropped from 37,000 to 25,000 cases by November 2020. Similarly, stent placements and other interventional procedures saw a notable reduction.
In the U.S., research presented at The Society of Thoracic Surgeons’ 57th Annual Meeting revealed a 53% nationwide decline in adult cardiac surgeries due to the pandemic. Public Health England data also indicates over 5,700 excess deaths from heart disease and stroke since the onset of COVID-19, with delayed surgeries likely contributing to this increased mortality rate.
Despite these short-term setbacks, the long-term demand for cardiovascular needles remains strong, driven by the persistent burden of cardiovascular diseases and the eventual resumption of deferred surgeries.
Europe Cardiovascular Needle Strategic Insights
Strategic insights for the Europe Cardiovascular Needle provides data-driven analysis of the industry landscape, including current trends, key players, and regional nuances. These insights offer actionable recommendations, enabling readers to differentiate themselves from competitors by identifying untapped segments or developing unique value propositions. Leveraging data analytics, these insights help industry players anticipate the market shifts, whether investors, manufacturers, or other stakeholders. A future-oriented perspective is essential, helping stakeholders anticipate market shifts and position themselves for long-term success in this dynamic region. Ultimately, effective strategic insights empower readers to make informed decisions that drive profitability and achieve their business objectives within the market.
Market leaders and key company profiles
ď‚· Ethicon (Johnson & Johnson Services, Inc.)
ď‚· MANI, INC
ď‚· Barber of Sheffield
ď‚· FSSB surgical needles GmbH
ď‚· Medtronic
ď‚· Teleflex Incorporated
ď‚· Meril Life Sciences Pvt. Ltd.
ď‚· CP Medical
ď‚· SMB Corporation of India
Regional Insights: Europe Cardiovascular Needle Market
The Europe Cardiovascular Needle market encompasses the specific regions where a company operates and competes. Recognizing regional variations—such as differences in product preferences (e.g., specialized needle designs or material requirements), economic factors, and regulatory standards—is essential for customizing strategies to local markets. By identifying underserved regions or adapting products to meet regional needs, businesses can expand their market presence. A well-defined regional focus enables efficient resource allocation, localized marketing efforts, and stronger competitive positioning, ultimately driving growth in targeted areas.
Market Overview and Dynamics
The Cardiovascular needle market in Europe is expected to grow from US$ 24,408.5 thousands in 2021 to US$ 39,261.2 thousands by 2028; it is estimated to grow at a CAGR of 7.0% from 2021 to 2028. The prevalence of cardiovascular conditions is significantly rising in developing countries due to shift in lifestyle, and the modernization of commercial, industrial, and residential infrastructure; the modernized facilities result in reduced physical activities. On the other hand, stress levels continue to rise among people. Thus, these factors are driving the prevalence of cardiovascular conditions in developing countries. Further, these countries are significantly developing their healthcare facilities and services and are heading toward technological advancements. As per the study Global Burden of Disease in the Lancet, ~10 deaths are associated with this disease, which is equivalent to ~6.4 million deaths. Thus, emerging countries provide significant opportunities for the cardiovascular needles market players; they can enter these untapped or less explored markets with cost-effective products during the forecast period.
Key Market Segments
In terms of type, the round-bodied needles segment accounted for the largest share of the Europe cardiovascular needle market in 2020. In terms of application, the open-heart surgery segment accounted for the largest share of the Europe cardiovascular needle market in 2020. In terms of usage, the single use segment accounted for the largest share of the Europe cardiovascular needle market in 2020. In terms of end user, the hospitals and clinics segment accounted for the largest share of the Europe cardiovascular needle market in 2020.
Major Sources and Companies Listed
A few major primary and secondary sources referred to for preparing this report on the cardiovascular needle market in Europe are company websites, annual reports, financial reports, national government documents, and statistical database, among others. Major companies listed in the report are Ethicon (Johnson & Johnson Services, Inc.), MANI, INC., Barber of Sheffield, FSSB surgical needles GmbH, Medtronic, Teleflex Incorporated, Meril Life Sciences Pvt. Ltd., CP Medical, and SMB Corporation of India.
Reasons to buy report
- To understand the Europe Cardiovascular needle market landscape and identify market segments that are most likely to guarantee a strong return
- Stay ahead of the race by comprehending the ever-changing competitive landscape for Europe Cardiovascular needle market
- Efficiently plan M&A and partnership deals in Europe Cardiovascular needle market by identifying market segments with the most promising probable sales
- Helps to take knowledgeable business decisions from perceptive and comprehensive analysis of market performance of various segment form Europe Cardiovascular needle market
- Obtain market revenue forecast for market by various segments from 2021-2028 in Europe region.
About Us:
Business Market Insights is a market research platform that provides subscription service for industry and company reports. Our research team has extensive professional expertise in domains such as Electronics & Semiconductor; Aerospace & DĂ©fense; Automotive & Transportation; Energy & Power; Healthcare; Manufacturing & Construction; Food & Beverages; Chemicals & Materials; and Technology, Media, & Telecommunications
Author’s Bio
Akshay
Senior Market Research Expert at Business Market Insights
